Loading
Laboratorios Farmaceuticos Rovi, S.A. Stock: price and insider trades · Spain
No insider purchase over the last 90 days. The latest, by Marina del Corral Téllez, was filed 23 Jun 2023.
Laboratorios Farmaceuticos Rovi, S.A.: what insiders have been doing
Laboratorios Farmaceuticos Rovi, S.A., founded in 1946, is a Health Care company based in Madrid, Spain. Its latest reported headcount is 1,419 employees (2024). Its directors and officers file their transactions with CNMV. Laboratorios Farmaceuticos Rovi, S.A. has had no insider filing for more than a year; the last one goes back to 23 June 2023.
Looking back to 2018, when coverage begins, insiders filed 2 purchases and 5 sales.
Every figure here comes from the filings published by CNMV and describes the past, not future prices; it is not investment advice.
Insider Decl.
17
Thresholds
n/a
Buy Volume
€2M
2 ops. · all time
Sell Volume
€340M
5 ops. · all time
Since the insiders bought
- +103.3%Entry €41.10 · Close at T+365 €83.55
- -15.5%Entry €59.50 · Close at T+365 €50.25
Entry is the close on the day after publication, the first price a reader could act on. Prices in the listing currency. Past moves are not a forecast.
Analyst consensus: bullish or bearish?
Analysts rate Laboratorios Farmaceuticos Rovi, S.A. Buy (bullish), based on 9 analysts. Average price target: €73.24.
This score ranks the purchase within its own market. A position size is suggested only on the venues of the backtested strategy universe; elsewhere, signals stay on watch. Not investment advice.
Fundamental score
Ranked 4,398 of 26,280 companies
69.0
score / 100
Value53
Quality85
FCF yld4.0%
Earn yld4.8%
EV/EBITDA14.2x
ROE29%
Gross mgn65%
Net mgn19%
Debt/EBITDA0.6x
Pillars2/3
Transparent value + quality ranking, distinct from the insider signal.
Financial data
as of FY 2025FY ended December 2025 · cache
€57.60
Analyst consensus
9 analystsBuy
€64.20Target €73.24(+27%)€83.00
Income statement
Revenue€743.5M
Gross profit€482.7M65% margin
EBITDA€216.2M29% margin
Net income€140.4M24.0% margin
Valuation
PER (trailing)15.9x
PER (forward)17.5x
P/Book4.2x
Beta0.27
Balance sheet & cash
Market cap€2.9B
Total debt€121.7M
Free Cash Flow€119.3M
Debt / Equity15%
Profitability & ownership
ROE28.7%
ROA9.4%
% insiders68.2%
% institutions16.7%
Last declaration on 23 June 2023
Declarations17 total
1,000 shares@ €41.010.0014% mcap100.0% of flowShareXMCEISIN ES0157261019CNMV:2023077287
Canonical exit: 19 Sept 2023 (T+90)
560,690 shares@ €58.5013.0% of flowShareXXXXISIN ES0157261019CNMV:2022086128
560,690 shares@ €67.5015.1% of flowShareXXXXISIN ES0157261019CNMV:2022044674
2,803,448 shares@ €64.5071.9% of flowShareXXXXISIN ES0157261019CNMV:2022034270
11,752 shares@ €61.5051.1% of flowShareXXXXISIN ES0157261019CNMV:2021106132
35,256 shares@ €61.50100.0% of flowShareXXXXISIN ES0157261019CNMV:2021106152
Canonical exit: 26 Oct 2021 (T+90)
▼
Same trade as the filing by Javier López-Belmonte Encina, counted once
€723k31CNMV
11,752 shares@ €61.5051.1% of flowShareXXXXISIN ES0157261019CNMV:2021106136
▼
Same trade as the filing by Javier López-Belmonte Encina, counted once
€723k42CNMV
11,752 shares@ €61.5051.1% of flowShareXXXXISIN ES0157261019CNMV:2021106128
11,752 shares@ €58.9048.9% of flowShareXXXXISIN ES0157261019CNMV:2021092412
●
Same trade as the filing by Javier López-Belmonte Encina, counted once
€692k16CNMV
11,752 shares@ €58.9048.9% of flowShareXXXXISIN ES0157261019CNMV:2021092446
●
Same trade as the filing by Javier López-Belmonte Encina, counted once
€692k27CNMV
11,752 shares@ €58.9048.9% of flowShareXXXXISIN ES0157261019CNMV:2021092456
1,682,069 shares@ €52.25100.0% of flowShareXXXXISIN ES0157261019CNMV:2021088921
551,724 shares0ShareXMADISIN ES0157261019CNMV:2018128547
551,724 shares0ShareXMADISIN ES0157261019CNMV:2018115145
551,724 shares0ShareXMADISIN ES0157261019CNMV:2018115156
551,724 shares0ShareXMADISIN ES0157261019CNMV:2018115222
551,724 shares0ShareXMADISIN ES0157261019CNMV:2018115225
17 of 17 declarations
About Laboratorios Farmaceuticos Rovi, S.A.
Laboratorios Farmaceuticos Rovi, S.A. is a Spanish pharmaceutical company focused on the development and commercialization of medications. It is listed on the Spanish stock market, XMAD.
